• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2022 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • SOP Web STAT
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

Scientific Media

  • GDE – “Scientific Media @Leaders in Pharmaceutical Business Intelligence (LPBI)”

  • http://pharmaceuticalintelligence.com/

HQS – Boston, MA

OUR CURRENT PLAN FOR FUNDING

GDE’s Scientific Media Business

We need a TOP Scientific e-Publisher to acquire

– the Journal and

– the BioMed Series

Alternatively, we need a FOUNDATION that Specializes in Funding Scientific Media or Communications to fund the Journal and the BioMed e-Series allowing to MARKET the e-Books to Cardiologists, Oncologist, in the U.S. and in Europe, explore the Market for Medical Books in Japan and China.

A.  Open Access online Scientific Journal  COVERS

We are seeking a Scientific Publisher to Publish the Journal in China and other countries in South East Asia

B.  BioMed e-Series

We are seeking a Scientific Publisher to Market our Amazon.com Medicine e-Books and Books to Cardiologists and Oncologists in CHINA

C.  Biotech and Medicine REAL TIME Press Coverage using Social Media and Tweet Analytics

We are seeking to scale up this Business to cover Conferences in Biotech and Medicine in South East Asia. We developed a methodology for REAL TIME conference coverage by Domain Experts

NEWS

10/22/2015 – 

#1: STARTEGY for the Journal

To follow up on ALL the FOUR NEEDS — we need a DEDICATED BD IN SHANGHAI

#1 – NEED for Introduction to George Institute for Global Health, China

#2  – NEED for Introduction to GEORGE CLINICAL, Australia, See e-mail, Anne Sim

LPBI the site and journal would fit perfectly. I suggest a personal agreement with them for regular interviews and postings on our site according to each individual expertise. This can and should be one on one with resultant site and tweet analytics as deliverables. Then indivual companies can work with GDE or M3DP

#3 – NEED for Introduction to Investment Funds in Healthcare in Shanghai

#4 – Medical 3D BioPrinting (M3DP) – A System Integration Start Up [3D Printer Sales, R&D Biologics, BioMed&Medical Devices]

NEED for Introduction to Private Equity INVESTOR(S) for Funding, Developing and Managing

@@@@@@@@@@@

#2: BASKET for GDE’s IT Issues

http://pharmaceuticalintelligence.com/2015/10/17/basket-for-gdes-it-issues/

@@@@@@@@@@@

  • Scientific Journal

http://pharmaceuticalintelligence.com/

On 9/23/2015

740,940 Readers

3,294 Scientific Articles

385 Categories of Research

7,106 Tags

NEWS

  • BioMed e-Series

10/22/2015

Our Director of Business Development for the Benelux and Scandinavian Counties, based in Amsterdam, Mr. Silvester Werring, has contacted on behalf of LPBI, the President of Elsevier.

Updates will follow.

Continue reading,

This e-mail is an example for

1. CONTINUOUS IMPROVEMENT procedures taking place at our BioMed e-Series

2. Collaborations among Editors Cross e-Series

3. Interaction among Editors and Editor-in-Chief

4. Parallel activities on “Marketing and Business Development” and “Editorial Development” for:

4.1 Series B: Volume one in Draft on Amazon ready for Upload, Volume Two in preliminary preparations

4.2 Series D – Decisions needed on Development, Beyond Volume 1 published in 2015 on Amazon.

4.2 Series A is Under Defined Plan – on going:

Dr. Pearlman will show progress on a Quarterly basis for FOUR Hard Copies in 2016.

4.3 Series C – Decisions PENDING on work beyond Volumes 1, published in 2015 on Amazon, and Volume 2, NOW in QA,

regarding Future of Volume 3, 4

4.4 Series E – Volume 1, Needs Editor and Development of eTOCs,

Two volumes have been completed by Dr. Larry.

Volume 4 on Medical 3D BioPrinting, Work-in-Progress

All Titles launched by Aviva.

http://pharmaceuticalintelligence.com/biomed-e-books/

Series E: Patient-Centered Medicine — e-Books Title Plan for 2015-2016

onepage series BCDE covers

This page has the following sub pages.

  • Work-in-Progress Volume One: The Patient’s Voice: Personal Experience with Invasive Medical Procedures
  • 90% DONE Volume Two: Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders
  • READY for AMAZON Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics
  • NEW TITLE Volume Four: Medical 3D BioPrinting – The Revolution in Medicine

Series C: Cancer Volume Two — Deadline PENDING for Dr. Sag and Dr. Raphael Nir

NEWS

  • Biotech and Medicine Conferences — REAL TIME Press Coverage using Social Media and Tweet Analytics

http://pharmaceuticalintelligence.com/2015/08/15/press-release-on-amazon-com-biomedical-e-books-e-series-by-the-team-of-leaders-in-pharmaceutical-business-intelligence-cardiovascular-genomics-cancer-biomed-patient-centered-medicine/

Forthcoming

The 11th Annual Personalized Medicine Conference, November 18-19, 2015, Joseph B. Martin Conference Center of the Harvard New Research Building at Harvard Medical School

http://pharmaceuticalintelligence.com/2015/07/09/the-11th-annual-personalized-medicine-conference-november-18-19-2015-joseph-b-martin-conference-center-of-the-harvard-new-research-building-at-harvard-medical-school/

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to print (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 9,459 other subscribers
  • Recent Posts

    • Creating a Twitter Space for @pharma_BI for Live Broadcasts March 14, 2023
    • The Vibrant Philly Biotech Scene: Recent Happenings & Deals March 11, 2023
    • Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes March 7, 2023
    • Merck’s sotatercept overachieves, PCSK9 inhibitor passes phase 2 March 6, 2023
    • Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic March 1, 2023
    • Genetic variation causes human lupus, systemic lupus erythematosus (SLE) February 23, 2023
    • Mimicking vaginal cells and microbiome interactions on chip microfluidic culture February 14, 2023
    • Press Release for Five Bilingual BioMed e-Series in English and in Spanish January 29, 2023
    • 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
    • Verily announced other organizational changes, 1/13/2023 January 16, 2023
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 Amandeep Kaur
    • 1 Aashir Awan, Phd
    • 1 Abhisar Anand
    • 1 Adina Hazan
    • 1 Alan F. Kaul, PharmD., MS, MBA, FCCP
    • 1 alexcrystal6
    • 1 anamikasarkar
    • 1 apreconasia
    • 1 aviralvatsa
    • 1 David Orchard-Webb, PhD
    • 1 danutdaagmailcom
    • 1 Demet Sag, Ph.D., CRA, GCP
    • 1 Dror Nir
    • 1 dsmolyar
    • 1 Ethan Coomber
    • 1 evelinacohn
    • 1 Gail S Thornton
    • 1 Irina Robu
    • 1 jayzmit48
    • 1 jdpmd
    • 1 jshertok
    • 1 kellyperlman
    • 1 Ed Kislauskis
    • 1 larryhbern
    • 1 Madison Davis
    • 1 marzankhan
    • 1 megbaker58
    • 1 ofermar2020
    • 1 Dr. Pati
    • 1 pkandala
    • 1 ritusaxena
    • 1 Rick Mandahl
    • 1 sjwilliamspa
    • 1 Srinivas Sriram
    • 1 stuartlpbi
    • 1 Dr. Sudipta Saha
    • 1 tildabarliya
    • 1 vaishnavee24
    • 1 zraviv06
    • 1 zs22

Powered by WordPress.com.

WPThemes.


 

Loading Comments...
 

    %d bloggers like this: